Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2017		Jun. 30, 2016
Cash flows from operating activities:
Net loss	$ (1,251,873)		$ (808,162)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	28,764		27,814
Stock-based compensation	718,061		48,000
Change in warrant liability	(229,669)		0
Changes in operating assets and liabilities:
Inventory	(131,233)		(45,295)
Prepaid expenses	28,342		28,867
Accounts payable	165,266		(62,218)
Accrued expenses and accrued expenses – related parties	85,287		45,527
Customer deposits	1,537		118,500
Net cash used in operating activities	(585,518)		(646,967)
Cash flows from investing activities:
Cost of registering patents	(9,267)		(10,565)
Net cash used in investing activities	(9,267)		(10,565)
Cash flows from financing activities:
Principal payments on notes payable and notes payable – related parties	(42,090)		(36,772)
Issuance of common stock for cash	300,000		0
Net cash provided by (used in) financing activities	257,910		(36,772)
Effects of foreign currency exchange rates on cash	(2,192)		(1,486)
Net decrease in cash	(339,067)		(695,790)
Cash as of beginning of the period	398,290	[1]	745,078
Cash as of end of the period	59,223		49,288
Supplemental cash flow information:
Cash paid for interest	12,227		3,568
Supplemental disclosure of non-cash financing activities:
Financing of insurance premiums	$ 31,825		$ 31,500

[1] The condensed consolidated balance sheet as of December 31, 2016 has been prepared using information from the audited consolidated balance sheet as of that date.